ACC 2023 Conference Coverage


 

ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial

1,320 views
March 15, 2023
Comments 3
Login to view comments. Click here to Login